The agreement provides Lavi with the rights to sell in Israel and includes minimum purchase requirements.
SonaStar is used by neuro and general surgeons for removal of both hard and soft tumors while sparing most vessels. BoneScalpel is a tissue specific osteotomy device capable of making cuts through bone and hard tissue while largely preserving delicate soft tissue structures, the company said.
Michael McManus, Jr, president and CEO of Misonix, said: Misonix is very excited about Lavi joining our sales and distribution organization. We know Lavi as a premier distributor of advanced medical equipment in Israel. We are particularly pleased that they will be distributing two of our product platforms through their well-established channels.
Misonix, designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix’s therapeutic ultrasonic platform is the basis for several innovative medical technologies. Misonix’s proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications.